REGISTER

FR
Search
×
FR

Placeholder headline

This is just a placeholder headline

API MPMS CH 22.6: Testing Protocols for Gas Chromatographs : Reaffirmed

$

192

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 1174: Onshore Hazardous Liquid Pipeline Emergency Preparedness and Response : Reaffirmed

$

182

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 624: Type Testing of Rising Stem Valves Equipped with Flexible Graphite Packing for Fugitive

$

171

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 20G: Welding Services for Equipment used in the Petroleum and Natural Gas Industry : Reaffirmed

$

164

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 624: Errata 2

$

0.00

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 1173: Pipeline Safety Management Systems

$

167

BUY NOW

ISO 15197:2013

ISO 15197:2013 In vitro diagnostic test systems – Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus

CDN $312.00

SKU: 04df4f2d781a Category:

Description

ISO 15197:2013 specifies requirements for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples, for specific design verification procedures and for the validation of performance by the intended users. These systems are intended for self-measurement by lay persons for management of diabetes mellitus.

ISO 15197:2013 is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems.

Edition

2

Published Date

2013-05-14

Status

PUBLISHED

Pages

46

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

ISO 15197:2013 specifies requirements for in vitro glucose monitoring systems that measure glucose concentrations in capillary blood samples, for specific design verification procedures and for the validation of performance by the intended users. These systems are intended for self-measurement by lay persons for management of diabetes mellitus.

ISO 15197:2013 is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems.

Previous Editions

Can’t find what you are looking for?

Please contact us at: